Advanced search
Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 38, 2009 - Issue 5
Submit an article Journal homepage
122
Views
18
CrossRef citations to date
0
Altmetric
Original

Decreased Expression of T Lymphocyte Co-Stimulatory Molecule CD26 on Invariant Natural Killer T Cells in Systemic Lupus Erythematosus

P. T. Y. Wong Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
,
C. K. Wong Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
,
L. S. Tam Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
,
E. K. Li Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
,
D. P. Chen Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
&
C. W. K. Lam Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong; Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, MacauCorrespondence[email protected]
Pages 350-364 | Published online: 13 Aug 2009

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ashwani Sharma, Tarun Virmani, Anjali Sharma, Vaishnavi Chhabra, Girish Kumar, Kamla Pathak & Abdulsalam Alhalmi. (2022) Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance. Diabetes, Metabolic Syndrome and Obesity 15, pages 1845-1864.
Read now
Nasimudeen R. Jabir, Chelapram K. Firoz, Farid Ahmed, Mohammad A. Kamal, Salwa Hindawi, Ghazi A. Damanhouri, Hussein A. Almehdar & Shams Tabrez. (2017) Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease. Immunological Investigations 46:5, pages 526-535.
Read now

Articles from other publishers (16)

Ning Chen, Yijun Dai, Hui Li, Xianming Long, Jun Ke, Jiuyun Zhang, Hong Sun, Fei Gao, He Lin & Qing Yan. (2023) Increased ILT2+ natural killer T cells correlate with disease activity in systemic lupus erythematosus. Clinical Rheumatology 42:11, pages 3113-3121.
Crossref
Jie Huang, Xinxin Liu, Yingying Wei, Xinlu Li, Shupei Gao, Lingli Dong, Xiaoquan Rao & Jixin Zhong. (2022) Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease. Frontiers in Immunology 13.
Crossref
Shabnam Radbakhsh, Stephen L. Atkin, Luis E. Simental-Mendia & Amirhossein Sahebkar. (2021) The role of incretins and incretin-based drugs in autoimmune diseases. International Immunopharmacology 98, pages 107845.
Crossref
Yi-Chuan Chen, Tien-Hsing Chen, Chi-Chin Sun, Jau-Yuan Chen, Shy-Shin Chang, Ling Yeung & Yi-Wen Tsai. (2020) Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study. Acta Diabetologica 57:10, pages 1181-1192.
Crossref
Gerhard Wingender & Mitchell Kronenberg. 2020. The Autoimmune Diseases. The Autoimmune Diseases 117 153 .
Pongpratch Puapatanakul, Sonchai Chansritrakul, Paweena Susantitaphong, Thornthun Ueaphongsukkit, Somchai Eiam-Ong, Kearkiat Praditpornsilpa, Wonngarm Kittanamongkolchai & Yingyos Avihingsanon. (2019) Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 20:19, pages 4954.
Crossref
Yunjuan Zhao. (2019) CD26 in autoimmune diseases: The other side of “moonlight protein”. International Immunopharmacology 75, pages 105757.
Crossref
Khalaf Kridin, Kyle Amber, Mogher Khamaisi, Doron Comaneshter, Erez Batat & Arnon D. Cohen. (2018) Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study. Immunologic Research 66:3, pages 425-430.
Crossref
Alessandra Torina, Giuliana Guggino, Marco La Manna & Guido Sireci. (2018) The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases. International Journal of Molecular Sciences 19:2, pages 440.
Crossref
Yalei Liu, Yuan Li, Yan Gong, Nan Yu, Yang Zhang, Ran You, Chenxue Qu, Guizhi Lu, Youyuan Huang, Ying Gao, Yanming Gao & Xiaohui Guo. (2018) CD26 expression is down-regulated on CD8+ T cells in patients with Hashimoto's thyroiditis. International Immunopharmacology 54, pages 280-285.
Crossref
Wen-Hsuan Hou, Kai-Cheng Chang, Chung-Yi Li & Huang-Tz Ou. (2016) Dipeptidyl peptidase-4 inhibitor use is not associated with elevated risk of severe joint pain in patients with type 2 diabetes: a population-based cohort study. Pain 157:9, pages 1954-1959.
Crossref
Seoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, Michael Doherty, Allison B Goldfine & Daniel H Solomon. (2015) Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study. Annals of the Rheumatic Diseases 74:11, pages 1968-1975.
Crossref
Junwei Chen, Meng Wu, Jing Wang & Xiaofeng Li. (2015) Immunoregulation of NKT Cells in Systemic Lupus Erythematosus. Journal of Immunology Research 2015, pages 1-8.
Crossref
Gerhard Wingender & Mitchell Kronenberg. 2014. The Autoimmune Diseases. The Autoimmune Diseases 103 129 .
Luziane Potrich Bellé, Paula Eliete Rodrigues Bitencourt, Karine Santos Bona, Régis Adriel Zanette, Rafael Noal Moresco & Maria Beatriz Moretto. (2011) Expression of CD26 and its Association with Dipeptidyl Peptidase IV Activity in Lymphocytes of Type 2 Diabetes Patients. Cell Biochemistry and Biophysics 61:2, pages 297-302.
Crossref
Kei Ohnuma, Osamu Hosono, Nam H. Dang & Chikao Morimoto. 2011. 51 84 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.